Yang Y, Liu Y, Sun H, Meng L, Lin H, Chen C, Hu J, Shen X, Duan M, Zhang Y, Abulaiti D, Wang J, Zhu H, Hua L, Leng Q, Zhang C, Sun L, Li W, Zhu H, Liu B, Wang J. Safety and efficacy of flumatinib as later-line therapy in patients with chronic myeloid leukemia. haematol [Internet]. 2024Dec.1 [cited 2026May19];109(12):3965-74. Available from: https://haematologica.org/article/view/haematol.2023.284892